Subscribe Now Subscribe Today

Who Plays Dual Role in Cancerous and Normal Cells? Natural Antioxidants or Free Radicals or the Cell Environment

Soodabeh Saeidnia and Mohammad Abdollahi
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail

Not Available.

Related Articles in ASCI
Search in Google Scholar
View Citation
Report Citation

  How to cite this article:

Soodabeh Saeidnia and Mohammad Abdollahi, 2012. Who Plays Dual Role in Cancerous and Normal Cells? Natural Antioxidants or Free Radicals or the Cell Environment. International Journal of Pharmacology, 8: 711-712.

DOI: 10.3923/ijp.2012.711.712

Received: September 18, 2012; Accepted: November 26, 2012; Published: January 04, 2013

In the recent years, the anticancer studies on the natural products and herbal medicines have been increased with the idea that these compounds can kill cancer cells or prevent their replication and progress. Most of the positive anticancer effects of the natural products have been claimed related to their antioxidant components. In the recent years most of studies support positive effects of natural antioxidants in many debilitating human diseases such as diabetes (Hosseini and Abdollahi, 2012), hyperprolactinemia (Hasani-Ranjbar et al., 2010), infertility (Momtaz and Abdollahi, 2010), or aging (Hasani-Ranjbar et al., 2012; Momtaz and Abdollahi, 2012) etc.

Medicinal plants produce diverse secondary metabolites, of which the most important classes are phenolic compounds characterizing by at least one aromatic ring (C6) and one or more hydroxyl groups. Antioxidant activity of phenolic compounds is due to their high tendency to chelate metals by possessing hydroxyl and carboxyl groups. The flavonoids and polyphenols can directly scavenge Reactive Oxygen Species (ROS) such as superoxide, hydrogen peroxide, hydroxyl radical, or other free radicals mainly by their ability to donate electrons or hydrogen atoms. Therefore, reduced forms of phenolic compounds or some vitamins such as A, C and E act as antioxidant, but phenoxyl radicals (the oxidized form) can cause cytotoxicity especially via prolonging the lifetime of the radicals by spin-stabilization. The phenoxyl radicals are generally toxic to living systems, by initiating free-radical chain reactions in the membrane (Michalak, 2006). Thus, it can be imagined that antioxidants play dual role in treatment and prevention of cancer (Abdollahi and Shetab-Boushehri, 2012). This may be due to the dual role of ROS in cancer, because the high levels of which are either essential for cancer development or making them susceptible to ROS-induced cell death in comparison to normal cells (Lopez-Lazaro, 2007).

Interestingly, a mode of action for some anticancer drugs involves the generation of free radicals to cause cellular damage and necrosis of malignant cells. A concern has gradually developed as “How can antioxidant compounds reduce the beneficial effect of chemotherapy on malignant cells?” As for instance, antioxidants are able to interfere with the oxidative mechanisms of alkylating agents, which cause DNA damage and cell necrosis. It is notable that chemotherapy damages are usually created by sort of other mechanisms toward apoptosis. Hence, the argument that antioxidants are likely to interfere with most chemotherapies cannot be extrapolated to all drugs. Although, there are no sufficient in vivo evidences to confirm that vitamins E, C and A might reduce the efficacy of chemotherapy but there are reports that beta-carotenes reduce the in vivo effect of 5-fluorouracil on one type of tumor, and also vitamin C induces kind of resistance to doxorubicin in resistant breast cancer cells (Lamson and Brignall, 1999).

Furthermore, while many papers highlight the beneficial role of natural antioxidant in cancer prevention, several clinical trials in the 1990s in different populations brought up with different achievements such as reduction of gastric cancer cells while increasing the lung cancer cells. As a result, the other question is “How might antioxidants prevent cancer?” In fact, antioxidants wipe up free radicals, by neutralizing the electrical charges and preventing the free radicals taking electrons from other molecules. But the concern raised from this conception is by which mode of action, a natural antioxidant is able to defense normal cells against cancer inducers (; Omenn et al., 1994).

This concept is being more complicated when one discusses about the phenolic compounds which are able to act as both antioxidant and pro-oxidant. The antioxidant activity might enhance the growth occurring in transformed cells, but undesirable pro-oxidant activity could damage the DNA and cellular membranes. However, cells response because of abnormal regulatory function and activity depending on extracellular and intracellular micro-oxygen environment can be different. Another challenge facing the concept is the lack of sufficient computational biology approaches to help researchers in this field.

Taking collectively, the main question still stands and so we recommend researchers to try doing tests in both normal and cancerous cells simultaneously to predict whether a natural antioxidant may show a beneficial or detrimental effect. To reach convincing conclusions, it is important to mention that anticancer effects of antioxidants mainly come from in vitro evidences while there are many challenges on reliability of such models due to use of frequently passaged cultured cells (Shetab-Boushehri and Abdollahi, 2012). Also, it is essential to consider and identify the anticancer mechanisms more than antioxidant effects for any compound that is hypothesized to be both antioxidant and anticancer. Therefore, the question of whether an antioxidant compound can be cytotoxic for cancer cells is still unanswered by current evidences.


  1. Abdollahi, M. and S.V. Shetab-Boushehri, 2012. Is it right to look for anti-cancer drugs amongst compounds having antioxidant effect? DARU J. Pharm. Sci., Vol. 20.
    CrossRef  |  Direct Link  |  

  2. Hasani-Ranjbar, S., H. Vahidi, S. Taslimi, N. Karimi, B. Larijani and M. Abdollahi, 2010. A systematic review on the efficacy of herbal medicines in the management of human drug-induced hyperprolactinemia; Potential sources for the development of novel drugs. Int. J. Pharmacol., 6: 691-695.
    CrossRef  |  Direct Link  |  

  3. Hasani-Ranjbar, S., S. Khosravi, N. Nayebi, B. Larijani and M. Abdollahi, 2012. Systematic review of the efficacy and safety of anti-aging herbs in animals and human. Asian J. Anim. Vet. Adv., 7: 621-640.
    CrossRef  |  Direct Link  |  

  4. Hosseini, A. and M. Abdollahi, 2012. It is time to formulate an antioxidant mixture for management of diabetes and its complications: Notice for pharmaceutical industries. Int. J. Pharmacol., 8: 60-61.
    CrossRef  |  Direct Link  |  

  5. Lamson, D.W. and M.S. Brignall, 1999. Antioxidants in cancer therapy: Their actions and interactions with oncologic therapies. Altern. Med. Rev., 4: 304-329.
    PubMed  |  

  6. Lopez-Lazaro, M., 2007. Dual role of hydrogen peroxide in cancer: Possible relevance to cancer chemoprevention and therapy. Cancer Lett., 252: 1-8.
    CrossRef  |  PubMed  |  

  7. Michalak, A., 2006. Phenolic compounds and their antioxidant activity in plants growing under heavy metal stress. Polish J. Environ. Stud., 15: 523-530.
    Direct Link  |  

  8. Momtaz, S. and M. Abdollahi, 2010. An update on pharmacology of Satureja species; From antioxidant, antimicrobial, antidiabetes and anti-hyperlipidemic to reproductive stimulation. Int. J. Pharmacol., 6: 346-353.
    CrossRef  |  Direct Link  |  

  9. Momtaz, S. and M. Abdollahi, 2012. A comprehensive review of biochemical and molecular evidences from animal and human studies on the role of oxidative stress in aging: An epiphenomenon or the cause. Asian. J. Anim. Vet. Adv. 7: 1-19.
    CrossRef  |  

  10. Omenn, G.S., G. Goodman, M. Thornquist, J. Grizzle and L. Rosenstock et al., 1994. The β-Carotene and Retinol Efficacy Trial (CARET) for chemoprevention of lung cancer in high risk populations: Smokers and asbestos-exposed workers. Cancer Res., 54: 2038s-2043s.
    PubMed  |  

  11. Shetab-Boushehri, S.V. and M. Abdollahi, 2012. Current concerns on the validity of In vitro models that use transformed neoplastic cells in pharmacology and toxicology. Int. J. Pharmacol., 8: 594-595.
    CrossRef  |  Direct Link  |  

©  2022 Science Alert. All Rights Reserved